📣Today, we're announcing our partnership with Progress Clinical Research and Brain Research Center, the leading drug research institutes in the Netherlands, specializing in a wide range of diseases from #Alzheimer's, #Parkinson's & #Dementia, to #Cardiometabolic and #Immunology.

Every year, the Slush 100 startup competition puts the world’s boldest early-stage companies on stage in front of a 13,000+ hyper-relevant crowd. The winner takes home the €1M investment prize, but even making it to the stage unlocks unique opportunities. Let’s take a look at how some of the past years’ participants have made the most of it: 🔹 @OASYSNOW, Winner 2024 Launched ELaiGIBLE, an AI platform matching patients to clinical trials, and secured partnerships with several trial sites. The company’s co-founder, Sara Okhuijsen, was named to Forbes 30 Under 30 in 2025. 🔹 Signatur Biosciences, Semifinalist 2024 Develops biomarker discovery technology to improve drug development. The startup’s CEO, Celestin de Wergifosse, joined Forbes 30 Under 30, and the company raised a $7M seed round in 2025. 🔹 Lendorse, Semifinalist 2024 Offers income-share agreements to help students fund their education. Closed a €1.75M seed round in 2025. 🔹 @Faircado, Winner 2023 Closed a €3M pre-seed round to accelerate its AI-powered browser extension that finds second-hand alternatives while you shop online. 🔹 @TeamHormona, Winner 2021 A digital health platform helping women track and understand their hormonal health. Now at €10M in total funding, with their latest raise in May 2025. 🔹 @CybelAngel, Winner 2016 Provides AI-powered external threat detection to prevent data leaks and cyber risks. Raised over €30M in a 2020 Series B, bringing total funding to around €50M. 🔹 BetterDoctor, Winner 2013 Built a platform for finding and verifying healthcare providers. Raised a Series B in 2017 before being acquired in 2018. 🔹 @fishbrainapp, Winner 2012 The world’s largest social network and app for anglers. Now valued at over €100M, with more than €50M raised, with the latest round in August 2023. Join the startups who’ve turned a Slush 100 pitch into their next big leap. Applications close soon, apply today 👉 slush.org/slush100 60% of startup tickets are sold. Get yours now 👉 slush.org/tickets

How can you make sharing health data as easy as logging onto Spotify? And how can you do this while safeguarding their privacy? In episode 98 of Women Disrupting Tech, @OASYSNOW founders Sara and Nima tell their story: open.spotify.com/episode/2C4… #WomenDisruptingTech

What if accessing your own health data was as easy as logging into Spotify? In episode 98 of Women Disrupting Tech, Sara Okhuijsen and Nima Salami share how @OASYSNOW is making personalized medicine secure, inclusive, and accessible. Check their story at open.spotify.com/episode/2C4…

We’re proud to see four Slushers on this year’s @Forbes 30 Under 30 Europe list. Shoutout to: 🔹 @ainobergius—CEO at Slush, and a longtime contributor to the ecosystem, starting from volunteering back in 2014. 🔹Mikko Mäntylä—Former President of Slush. Currently building Realm, an always-online AI teammate that helps revenue teams deliver world-class service. 🔹Antonia Eneh—Head of Finance at Slush 2023. Now leading @WaveVentures, Europe’s largest student-run VC fund that backs the most exceptional Gen Z founders in the New Nordics. 🔹 Olli Kangas—Former Slush volunteer, now building Intergrid, a Helsinki-based startup optimizing electric industrial heat production. We couldn’t be more excited to cheer you on as you keep shaping what’s next in the ecosystem. Also, sending massive cheers to Slush 100 participants building the future of healthcare who made it to the list: 🔹 Sara Okhuijsen–CTO & Co-Founder of @OASYSNOW (Slush 100 2024 Winner), on a mission to make personalized healthcare and precision medicine accessible to all. 🔹 Celestin de Wergifosse–Co-Founder & CEO of Signatur Biosciences (Slush 100 Top 20), expanding access to precision diagnostics—starting with breast cancer testing for women around the world. And there’s even more to celebrate: Helsinki is in Forbes’ Top 5 European cities for founders, right up there with London, Paris, Berlin, and Munich. A huge congrats to everyone building and pushing the Finnish startup scene forward—this one’s for you 💚

Most clinical trials fail. Most health data excludes most people. In episode 98 of Women Disrupting Tech, Sara Okhuijsen and Nima Salami share how @oasysnow is building a future where personalized medicine works for everyone. Check out their story at spoti.fi/42wHlm3

OASYS NOW is now 4 years old!

🎊Our alumnus @OkhuijsenSara & @EEMCS_TUD alumnus @Nima_Salami won the @SlushHQ startup competition in Helsinki with their startup @OASYSNOW. They aim to enable personalised #healthcare and empower patients to take control of their own data. Congrats! Photo credits: @PetriAPhoto

Congratulations @OASYSNOW for winning the #slush100 #slush2024 pitching and 1 000 000 Eur! The pitch was awesome! Great to see #MyData -aligned solutions in health gaining such great recognition! #personaldata #dataprivacy #dataempowerment

Thank you, @NVIDIAEU! We're a happy NVIDIA Inception member and enjoy the collaboration with your FL and Privacy team!

🎉 Congratulations to NVIDIA Inception member @OASYSNOW on winning the Slush startup competition!👏 Learn about our startup program: nvda.ws/3Z4crOM. @SlushHQ #Slush100 #Slush2024

13.000 people in Finnland 🇫🇮, all committed to building the future! 13.000 reasons to be excited and optimistic for European #Tech! Thank you for a great @SlushHQ 2024. Incredible job by the #slush2024 team, especially to the hundreds of volunteers. And CONGRATS to the winners of the #slush100 startup competition- OASISnow! Welcome to the @generalcatalyst and @CherryVentures portfolio! 🍒🚀

We’re thrilled to unveil this year’s Slush 100 winner: OASYS NOW OASYS NOW is revolutionizing health tech. Their hard work and vision have won them the grand prize: a €1M equity investment from our esteemed VC partners—General Catalyst and Cherry Ventures. Congratulations to the entire team. This is just the beginning. Note: Final investment from participating funds subject to closing and due diligence. 📸: Otto Jahnukainen #Slush100 #Slush2024

Proud to support this petition for a unified pan-European startup entity. Let’s unite Europe's startup ecosystems! eu-inc.org 🇪🇺 eu-inc.org/

We made it to the top 50 of @SlushHQ 100! 🍒Cherry-picked by @CherryVentures and @generalcatalyst! 🎉 On a mission to make Personalized Medicine accessible and equitable to everyone globally!

After much anticipation, the top 50 startups for Slush 100 have been selected. These top startups are transforming industries like deeptech, fintech, medtech, software, and more. But the journey doesn’t stop here—next up is the race to the top 20. The 50 startups will soon receive a form to submit their pitch videos, from which the top 20 will be chosen. Good luck to all the startups vying for a spot in the final round, where one groundbreaking company will win €1,000,000 investment from @generalcatalyst and @CherryVentures Who’s ready to witness the next unicorn at Slush 2024? 🙋 Read more: slush.org/startups/slush-100… #slush100 #slush2024

We are delighted that so many ambitious startups applied for the first ELSA Open Call! Our five winners have now been announced: @Algomocom, @OASYSNOW, @OttCT, QuantPi and @Sarus_tech will receive funding and work with ELSA on secure AI applications. elsa-ai.eu/winners-call

OASYS NOW focusses on developing patient-centric, privacy-first technologies that revolutionize how health data is used in clinical research and healthcare. Read more about @OASYSNOW supported by the first ELSA open call here: oasysnow.com/